1. Volume 145, Issue 2, Pages 361-365 (May 2017)
Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer 
Maria Lee, Eun Jae Kim, Youngnam Cho, Sunshin Kim, Hyun Hoon Chung, Noh Hyun Park, Yong-Sang Song 
Gynecologic Oncology 
Volume 145, Issue 2, Pages (May 2017)
DOI: /j.ygyno
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1 Immunohistochemistry of captured and subcultured CTCs.
A) Up: Immunocytochemistry of single CTCs recovered from peripheral blood, as seen by confocal microscopy (green, EpCAM; blue, DAPI; red, CD45; purple, vimentin) and bottom: Immunocytochemistry of clustered CTCs recovered from peripheral blood, as seen by confocal microscopy (green, EpCAM; blue, DAPI); and B) cultured CTCs resembling originally captured parent cells (20× magnification, all panels).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions

3. Fig. 2
Responsiveness of captured and subcultured CTCs to chemotherapeutic agents.
A, B) CTC cell lines (P10, P14) showing greater sensitivity to cisplatin and paclitaxel than do SKOV3 or OVCAR3 cells; and C) more rapid proliferation of isolated CTCs, relative to SKOV3 or OVCAR3 cells.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions

4. Supplementary Fig. 1
Kaplan-Meier curves showing progression-free survival (A) and overall survival (B) of newly diagnosed patients according to CTC count (CTCs ≥3 vs. <3). Kaplan-Meier plots demonstrated that patients had CTCs ≥3 had significantly worse progression-free survival (P=0.013).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions

5. Supplementary Fig. 2
Kaplan-Meier curves showing progression-free survival (A) and overall survival (B) of patients with recurrences according to CTC count (CTCs ≥3 vs. <3). CTC count had no statistical significance on PFS and OS (P=0.334 and P=0.190, respectively).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions